<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38785545</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1467-3045</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>Current issues in molecular biology</Title><ISOAbbreviation>Curr Issues Mol Biol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer's Disease.</ArticleTitle><Pagination><StartPage>4565</StartPage><EndPage>4579</EndPage><MedlinePgn>4565-4579</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/cimb46050277</ELocationID><Abstract><AbstractText>Type I interferon signaling (IFN-I) perturbations are major drivers of COVID-19. Dysregulated IFN-I in the brain, however, has been linked to both reduced cognitive resilience and neurodegenerative diseases such as Alzheimer's. Previous works from our group have proposed a model where peripheral induction of IFN-I may be relayed to the CNS, even in the absence of fulminant infection. The aim of our study was to identify significantly enriched IFN-I signatures and genes along the transolfactory route, utilizing published datasets of the nasal mucosa and olfactory bulb amygdala transcriptomes of COVID-19 patients. We furthermore sought to identify these IFN-I signature gene networks associated with Alzheimer's disease pathology and risk. Gene expression data involving the nasal epithelium, olfactory bulb, and amygdala of COVID-19 patients and transcriptomic data from Alzheimer's disease patients were scrutinized for enriched Type I interferon pathways. Gene set enrichment analyses and gene-Venn approaches were used to determine genes in IFN-I enriched signatures. The Agora web resource was used to identify genes in IFN-I signatures associated with Alzheimer's disease risk based on its aggregated multi-omic data. For all analyses, false discovery rates (FDR) &lt;0.05 were considered statistically significant. Pathways associated with type I interferon signaling were found in all samples tested. Each type I interferon signature was enriched by IFITM and OAS family genes. A 14-gene signature was associated with COVID-19 CNS and the response to Alzheimer's disease pathology, whereas nine genes were associated with increased risk for Alzheimer's disease based on Agora. Our study provides further support to a type I interferon signaling dysregulation along the extended olfactory network as reconstructed herein, ranging from the nasal epithelium and extending to the amygdala. We furthermore identify the 14 genes implicated in this dysregulated pathway with Alzheimer's disease pathology, among which HLA-C, HLA-B, HLA-A, PSMB8, IFITM3, HLA-E, IFITM1, OAS2, and MX1 as genes with associated conferring increased risk for the latter. Further research into its druggability by IFNb therapeutics may be warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vavougios</LastName><ForeName>George D</ForeName><Initials>GD</Initials><Identifier Source="ORCID">0000-0002-0413-4028</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of Cyprus, Nicosia 1678, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mavridis</LastName><ForeName>Theodoros</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5952-5106</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Tallaght University Hospital (TUH)/The Adelaide and Meath Hospital, Dublin, Incorporating the National Children's Hospital (AMNCH), D24 NR0A Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doskas</LastName><ForeName>Triantafyllos</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Athens Naval Hospital, 115 21 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papaggeli</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Molecular Virology Laboratory, Hellenic Pasteur Institute, 115 21 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foka</LastName><ForeName>Pelagia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6888-7678</Identifier><AffiliationInfo><Affiliation>Molecular Virology Laboratory, Hellenic Pasteur Institute, 115 21 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadjigeorgiou</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5386-4273</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of Cyprus, Nicosia 1678, Cyprus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COVALENT and COGNATE studies (No grant number applicable)</GrantID><Agency>Cyprus Academy of Letters and Arts</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Issues Mol Biol</MedlineTA><NlmUniqueID>100931761</NlmUniqueID><ISSNLinking>1467-3037</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">IFITM3</Keyword><Keyword MajorTopicYN="N">cGAS-STING</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">nasal epithelial cells</Keyword><Keyword MajorTopicYN="N">type I interferon signaling</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38785545</ArticleId><ArticleId IdType="pmc">PMC11119810</ArticleId><ArticleId IdType="doi">10.3390/cimb46050277</ArticleId><ArticleId IdType="pii">cimb46050277</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Erausquin G.A., Snyder H., Carrillo M., Hosseini A.A., Brugha T.S., Seshadri S. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimer&#x2019;s Dement. 2021;17:1056&#x2013;1065. doi: 10.1002/alz.12255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12255</ArticleId><ArticleId IdType="pmc">PMC10431934</ArticleId><ArticleId IdType="pubmed">33399270</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavougios G.D., Nday C., Pelidou S.H., Gourgoulianis K.I., Stamoulis G., Doskas T., Zarogiannis S.G. Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer&#x2019;s disease. Brain Behav. Immun. Health. 2021;14:100243. doi: 10.1016/j.bbih.2021.100243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100243</ArticleId><ArticleId IdType="pmc">PMC7997139</ArticleId><ArticleId IdType="pubmed">33817671</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavougios G.D., de Erausquin G.A., Snyder H.M. Type I interferon signaling in SARS-CoV-2 associated neurocognitive disorder (SAND): Mapping host-virus interactions to an etiopathogenesis. Front. Neurol. 2022;13:1063298. doi: 10.3389/fneur.2022.1063298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1063298</ArticleId><ArticleId IdType="pmc">PMC9771386</ArticleId><ArticleId IdType="pubmed">36570454</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan P.H., Ji J., Hsing C.H., Tan R., Ji R.R. Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID. Int. J. Mol. Sci. 2022;23:14394. doi: 10.3390/ijms232214394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232214394</ArticleId><ArticleId IdType="pmc">PMC9696119</ArticleId><ArticleId IdType="pubmed">36430870</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzzi S., Tsitsou-Kampeli A., Schwartz M. The type I interferon antiviral response in the choroid plexus and the cognitive risk in COVID-19. Nat. Immunol. 2023;24:220&#x2013;224. doi: 10.1038/s41590-022-01410-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01410-z</ArticleId><ArticleId IdType="pubmed">36717725</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini S., Michaelsen-Preusse K., Grigoryan G., Chhatbar C., Kalinke U., Korte M. Type I Interferon Receptor Signaling in Astrocytes Regulates Hippocampal Synaptic Plasticity and Cognitive Function of the Healthy CNS. Cell Rep. 2020;31:107666. doi: 10.1016/j.celrep.2020.107666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107666</ArticleId><ArticleId IdType="pubmed">32433975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekdahl C.T., Claasen J.-H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA. 2003;100:13632&#x2013;13637. doi: 10.1073/pnas.2234031100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2234031100</ArticleId><ArticleId IdType="pmc">PMC263865</ArticleId><ArticleId IdType="pubmed">14581618</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.S., Shin S.M., Kim S., Nam Y., Yoo A., Moon M. Relationship between adult subventricular neurogenesis and Alzheimer&#x2019;s disease: Pathologic roles and therapeutic implications. Front. Aging Neurosci. 2022;14:1002281. doi: 10.3389/fnagi.2022.1002281.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1002281</ArticleId><ArticleId IdType="pmc">PMC9518691</ArticleId><ArticleId IdType="pubmed">36185481</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy E., Cao W. Glial interference: Impact of type I interferon in neurodegenerative diseases. Mol. Neurodegener. 2022;17:78. doi: 10.1186/s13024-022-00583-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00583-3</ArticleId><ArticleId IdType="pmc">PMC9701358</ArticleId><ArticleId IdType="pubmed">36435817</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy E.R., Wang B., Wan Y.-w., Chiu G., Cole A., Yin Z., Propson N.E., Xu Y., Jankowsky J.L., Liu Z., et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J. Clin. Investig. 2020;130:1912&#x2013;1930. doi: 10.1172/JCI133737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI133737</ArticleId><ArticleId IdType="pmc">PMC7108898</ArticleId><ArticleId IdType="pubmed">31917687</ArticleId></ArticleIdList></Reference><Reference><Citation>Jana A., Wang X., Leasure J.W., Magana L., Wang L., Kim Y.-M., Dodiya H., Toth P.T., Sisodia S.S., Rehman J. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer&#x2019;s disease. Sci. Rep. 2022;12:16488. doi: 10.1038/s41598-022-20889-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-20889-y</ArticleId><ArticleId IdType="pmc">PMC9526723</ArticleId><ArticleId IdType="pubmed">36182964</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte N., Shafi A.M., Penha-Gon&#xe7;alves C., Pais T.F. Endothelial type I interferon response and brain diseases: Identifying STING as a therapeutic target. Front. Cell Dev. Biol. 2023;11:1249235. doi: 10.3389/fcell.2023.1249235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2023.1249235</ArticleId><ArticleId IdType="pmc">PMC10542901</ArticleId><ArticleId IdType="pubmed">37791071</ArticleId></ArticleIdList></Reference><Reference><Citation>Udeochu J.C., Amin S., Huang Y., Fan L., Torres E.R.S., Carling G.K., Liu B., McGurran H., Coronas-Samano G., Kauwe G., et al. Tau activation of microglial cGAS&#x2013;IFN reduces MEF2C-mediated cognitive resilience. Nat. Neurosci. 2023;26:737&#x2013;750. doi: 10.1038/s41593-023-01315-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-023-01315-6</ArticleId><ArticleId IdType="pmc">PMC10166855</ArticleId><ArticleId IdType="pubmed">37095396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur J.Y., Frost G.R., Wu X., Crump C., Pan S.J., Wong E., Barros M., Li T., Nie P., Zhai Y., et al. The innate immunity protein IFITM3 modulates &#x3b3;-secretase in Alzheimer&#x2019;s disease. Nature. 2020;586:735&#x2013;740. doi: 10.1038/s41586-020-2681-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2681-2</ArticleId><ArticleId IdType="pmc">PMC7919141</ArticleId><ArticleId IdType="pubmed">32879487</ArticleId></ArticleIdList></Reference><Reference><Citation>Prelli Bozzo C., Nchioua R., Volcic M., Koepke L., Kr&#xfc;ger J., Sch&#xfc;tz D., Heller S., St&#xfc;rzel C.M., Kmiec D., Conzelmann C., et al. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat. Commun. 2021;12:4584. doi: 10.1038/s41467-021-24817-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24817-y</ArticleId><ArticleId IdType="pmc">PMC8319209</ArticleId><ArticleId IdType="pubmed">34321474</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi G., Kenney A.D., Kudryashova E., Zani A., Zhang L., Lai K.K., Hall-Stoodley L., Robinson R.T., Kudryashov D.S., Compton A.A., et al. Opposing activities of IFITM proteins in SARS-CoV-2 infection. EMBO J. 2021;40:e106501. doi: 10.15252/embj.2020106501.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106501</ArticleId><ArticleId IdType="pmc">PMC7744865</ArticleId><ArticleId IdType="pubmed">33270927</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavougios G.D., Breza M., Mavridis T., Krogfelt K.A. FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer&#x2019;s disease. Brain Disord. 2021;3:100022. doi: 10.1016/j.dscb.2021.100022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dscb.2021.100022</ArticleId></ArticleIdList></Reference><Reference><Citation>Magusali N., Graham A.C., Piers T.M., Panichnantakul P., Yaman U., Shoai M., Reynolds R.H., Botia J.A., Brookes K.J., Guetta-Baranes T., et al. Genetic variability associated with OAS1 expression in myeloid cells increases the risk of Alzheimer&#x2019;s disease and severe COVID-19 outcomes. bioRxiv. 2021 doi: 10.1101/2021.03.16.435702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.16.435702</ArticleId><ArticleId IdType="pmc">PMC8500089</ArticleId><ArticleId IdType="pubmed">34619763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Xu J., Hou Y., Leverenz J.B., Kallianpur A., Mehra R., Liu Y., Yu H., Pieper A.A., Jehi L., et al. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimer&#x2019;s Res. Ther. 2021;13:110. doi: 10.1186/s13195-021-00850-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00850-3</ArticleId><ArticleId IdType="pmc">PMC8189279</ArticleId><ArticleId IdType="pubmed">34108016</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavougios G.D., Nday C., Pelidou S.H., Zarogiannis S.G., Gourgoulianis K.I., Stamoulis G., Doskas T. Double hit viral parasitism, polymicrobial CNS residency and perturbed proteostasis in Alzheimer&#x2019;s disease: A data driven, in silico analysis of gene expression data. Mol. Immunol. 2020;127:124&#x2013;135. doi: 10.1016/j.molimm.2020.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2020.08.021</ArticleId><ArticleId IdType="pubmed">32971399</ArticleId></ArticleIdList></Reference><Reference><Citation>Daroische R., Hemminghyth M.S., Eilertsen T.H., Breitve M.H., Chwiszczuk L.J. Cognitive Impairment After COVID-19&#x2014;A Review on Objective Test Data. Front. Neurol. 2021;12:1238. doi: 10.3389/fneur.2021.699582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.699582</ArticleId><ArticleId IdType="pmc">PMC8357992</ArticleId><ArticleId IdType="pubmed">34393978</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirker-Kees A., Platho-Elwischger K., Hafner S., Redlich K., Baumgartner C. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results. Dement. Geriatr. Cogn. Disord. 2021;50:68&#x2013;73. doi: 10.1159/000515575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000515575</ArticleId><ArticleId IdType="pmc">PMC8089429</ArticleId><ArticleId IdType="pubmed">33853062</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek M.S., Cho H., Lee H.S., Lee J.H., Ryu Y.H., Lyoo C.H. Effect of A/T/N imaging biomarkers on impaired odor identification in Alzheimer&#x2019;s disease. Sci. Rep. 2020;10:11556. doi: 10.1038/s41598-020-68504-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68504-2</ArticleId><ArticleId IdType="pmc">PMC7360607</ArticleId><ArticleId IdType="pubmed">32665636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafaille-Magnan M.-E., Poirier J., Etienne P., Tremblay-Mercier J., Frenette J., Rosa-Neto P., Breitner J.C.S., For the PREVENT-AD Research Group Odor identification as a biomarker of preclinical AD in older adults at risk. Neurology. 2017;89:327&#x2013;335. doi: 10.1212/WNL.0000000000004159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004159</ArticleId><ArticleId IdType="pmc">PMC5574678</ArticleId><ArticleId IdType="pubmed">28659431</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin G.A., Snyder H., Brugha T.S., Seshadri S., Carrillo M., Sagar R., Huang Y., Newton C., Tartaglia C., Teunissen C., et al. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer&#x2019;s Association Global Consortium. Alzheimer&#x2019;s Dement. 2022;8:e12348. doi: 10.1002/trc2.12348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12348</ArticleId><ArticleId IdType="pmc">PMC9494609</ArticleId><ArticleId IdType="pubmed">36185993</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler C.G.K., Miao V.N., Owings A.H., Navia A.W., Tang Y., Bromley J.D., Lotfy P., Sloan M., Laird H., Williams H.B., et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell. 2021;184:4713&#x2013;4733.e4722. doi: 10.1016/j.cell.2021.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.07.023</ArticleId><ArticleId IdType="pmc">PMC8299217</ArticleId><ArticleId IdType="pubmed">34352228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatton C.F., Botting R.A., Due&#xf1;as M.E., Haq I.J., Verdon B., Thompson B.J., Spegarova J.S., Gothe F., Stephenson E., Gardner A.I., et al. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2. Nat. Commun. 2021;12:7092. doi: 10.1038/s41467-021-27318-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27318-0</ArticleId><ArticleId IdType="pmc">PMC8651658</ArticleId><ArticleId IdType="pubmed">34876592</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrikaki M., Lee J.D., Solomon I.H., Slack F.J. Severe COVID-19 is associated with molecular signatures of aging in the human brain. Nature Aging. 2022;2:1130&#x2013;1137. doi: 10.1038/s43587-022-00321-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00321-w</ArticleId><ArticleId IdType="pubmed">37118539</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber G. The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19. Front. Immunol. 2020;11:595739. doi: 10.3389/fimmu.2020.595739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.595739</ArticleId><ArticleId IdType="pmc">PMC7561359</ArticleId><ArticleId IdType="pubmed">33117408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J.H., Kim J., Hong S.P., Choi S.Y., Yang M.J., Ju Y.S., Kim Y.T., Kim H.M., Rahman M.D.T., Chung M.K., et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J. Clin. Investig. 2021;131:e148517. doi: 10.1172/jci148517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci148517</ArticleId><ArticleId IdType="pmc">PMC8245175</ArticleId><ArticleId IdType="pubmed">34003804</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Li Z., Wachter A., Alla S., Noori A., Abdourahman A., Tamm J.A., Woodbury M.E., Talanian R.V., Biber K., et al. Distinct transcriptomic responses to A&#x3b2; plaques, neurofibrillary tangles, and APOE in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2024;20:74&#x2013;90. doi: 10.1002/alz.13387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.13387</ArticleId><ArticleId IdType="pmc">PMC10792109</ArticleId><ArticleId IdType="pubmed">37461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano G.E., Walker J.E., Tremblay C., Piras I.S., Huentelman M.J., Belden C.M., Goldfarb D., Shprecher D., Atri A., Adler C.H., et al. SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19. J. Neuropathol. Exp. Neurol. 2022;81:666&#x2013;695. doi: 10.1093/jnen/nlac056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlac056</ArticleId><ArticleId IdType="pmc">PMC9278252</ArticleId><ArticleId IdType="pubmed">35818336</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H., Adaikkan C., Gao F., Young J.Z., Manet E., Hemberg M., De Jager P.L., Ransohoff R.M., Regev A., Tsai L.H. Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution. Cell Rep. 2017;21:366&#x2013;380. doi: 10.1016/j.celrep.2017.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.09.039</ArticleId><ArticleId IdType="pmc">PMC5642107</ArticleId><ArticleId IdType="pubmed">29020624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M.V., Jones M.R., Rouillard A.D., Fernandez N.F., Duan Q., Wang Z., Koplev S., Jenkins S.L., Jagodnik K.M., Lachmann A., et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z., Bailey A., Kuleshov M.V., Clarke D.J.B., Evangelista J.E., Jenkins S.L., Lachmann A., Wojciechowicz M.L., Kropiwnicki E., Jagodnik K.M., et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 2021;1:e90. doi: 10.1002/cpz1.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpz1.90</ArticleId><ArticleId IdType="pmc">PMC8152575</ArticleId><ArticleId IdType="pubmed">33780170</ArticleId></ArticleIdList></Reference><Reference><Citation>Heberle H., Meirelles G.V., da Silva F.R., Telles G.P., Minghim R. InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform. 2015;16:169. doi: 10.1186/s12859-015-0611-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-015-0611-3</ArticleId><ArticleId IdType="pmc">PMC4455604</ArticleId><ArticleId IdType="pubmed">25994840</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Nastou K.C., Lyon D., Kirsch R., Pyysalo S., Doncheva N.T., Legeay M., Fang T., Bork P., et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605&#x2013;D612. doi: 10.1093/nar/gkaa1074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Ramirez A., Hosseini A., Vavougyios G., Lehmann C., Bruchfeld J., Schneider A., D&#x2019;Avossa G., Lo Re V., Salmoiraghi A., et al. European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19. Brain Connect. 2023;13:178&#x2013;210. doi: 10.1089/brain.2022.0058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/brain.2022.0058</ArticleId><ArticleId IdType="pubmed">36719785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayat A.H., Azimi H., Hassani Moghaddam M., Ebrahimi V., Fathi M., Vakili K., Mahmoudiasl G.R., Forouzesh M., Boroujeni M.E., Nariman Z., et al. COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus. Apoptosis. 2022;27:852&#x2013;868. doi: 10.1007/s10495-022-01754-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-022-01754-9</ArticleId><ArticleId IdType="pmc">PMC9310365</ArticleId><ArticleId IdType="pubmed">35876935</ArticleId></ArticleIdList></Reference><Reference><Citation>Muccioli L., Sighinolfi G., Mitolo M., Ferri L., Jane Rochat M., Pensato U., Taruffi L., Testa C., Masullo M., Cortelli P., et al. Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction. Neuroimage Clin. 2023;38:103410. doi: 10.1016/j.nicl.2023.103410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2023.103410</ArticleId><ArticleId IdType="pmc">PMC10165139</ArticleId><ArticleId IdType="pubmed">37104928</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruch K., Deczkowska A., David E., Castellano J.M., Miller O., Kertser A., Berkutzki T., Barnett-Itzhaki Z., Bezalel D., Wyss-Coray T., et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. 2014;346:89&#x2013;93. doi: 10.1126/science.1252945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1252945</ArticleId><ArticleId IdType="pmc">PMC4869326</ArticleId><ArticleId IdType="pubmed">25147279</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavougios G.D. Potentially irreversible olfactory and gustatory impairments in COVID-19: Indolent vs. fulminant SARS-CoV-2 neuroinfection. Brain Behav. Immun. 2020;87:107&#x2013;108. doi: 10.1016/j.bbi.2020.04.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.071</ArticleId><ArticleId IdType="pmc">PMC7185018</ArticleId><ArticleId IdType="pubmed">32353521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Shin E.-C. The type I interferon response in COVID-19: Implications for treatment. Nat. Rev. Immunol. 2020;20:585&#x2013;586. doi: 10.1038/s41577-020-00429-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00429-3</ArticleId><ArticleId IdType="pmc">PMC8824445</ArticleId><ArticleId IdType="pubmed">32788708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B., Ramaiah A., Garcia G., Jr., Hasiakos S., Arumugaswami V., Srikanth S. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling. J. Immunol. 2022;208:74&#x2013;84. doi: 10.4049/jimmunol.2100742.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100742</ArticleId><ArticleId IdType="pmc">PMC8702473</ArticleId><ArticleId IdType="pubmed">34819389</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R.-C., Huang K., Zhang H.-P., Li L., Zhang Y.-F., Tan C., Chen H.-C., Jin M.-L., Wang X.-R. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J. Neuroinflammation. 2022;19:149. doi: 10.1186/s12974-022-02514-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02514-x</ArticleId><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J., Lampe J., M&#xfc;ller-Fielitz H., Schuster R., Zille M., M&#xfc;ller K., Krohn M., K&#xf6;rbelin J., Zhang L., &#xd6;zorhan &#xdc;., et al. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat. Neurosci. 2021;24:1522&#x2013;1533. doi: 10.1038/s41593-021-00926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavougios G.D., Zarogiannis S.G., Hadjigeorgiou G., Krogfelt K.A., Gourgoulianis K.I. SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe. Stem Cell Rep. 2022;17:1012&#x2013;1013. doi: 10.1016/j.stemcr.2022.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.04.011</ArticleId><ArticleId IdType="pmc">PMC9087889</ArticleId><ArticleId IdType="pubmed">35545022</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong W., Montano M., Corley M.J., Helmy E., Kobayashi H., Kinisu M., Suryawanshi R., Luo X., Royer L.A., Roan N.R., et al. Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons. mBio. 2022;13:e0230822. doi: 10.1128/mbio.02308-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02308-22</ArticleId><ArticleId IdType="pmc">PMC9765283</ArticleId><ArticleId IdType="pubmed">36314791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong D., Park K.H., Kim D.-H., Kim N.G., Lee S.-E., Shin N., Kook M.G., Kim Y.B., Kang K.-S. Cortical-blood vessel assembloids exhibit Alzheimer&#x2019;s disease phenotypes by activating glia after SARS-CoV-2 infection. Cell Death Discov. 2023;9:32. doi: 10.1038/s41420-022-01288-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-022-01288-8</ArticleId><ArticleId IdType="pmc">PMC9876421</ArticleId><ArticleId IdType="pubmed">36697403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z.X., Wan Q., Xing A. HLA in Alzheimer&#x2019;s Disease: Genetic Association and Possible Pathogenic Roles. Neuromolecular Med. 2020;22:464&#x2013;473. doi: 10.1007/s12017-020-08612-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-020-08612-4</ArticleId><ArticleId IdType="pubmed">32894413</ArticleId></ArticleIdList></Reference><Reference><Citation>Haure-Mirande J.-V., Audrain M., Ehrlich M.E., Gandy S. Microglial TYROBP/DAP12 in Alzheimer&#x2019;s disease: Transduction of physiological and pathological signals across TREM2. Mol. Neurodegener. 2022;17:55. doi: 10.1186/s13024-022-00552-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00552-w</ArticleId><ArticleId IdType="pmc">PMC9404585</ArticleId><ArticleId IdType="pubmed">36002854</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavougios G.D., Mavridis T., Artemiadis A., Krogfelt K.A., Hadjigeorgiou G. Trained immunity in viral infections, Alzheimer&#x2019;s disease and multiple sclerosis: A convergence in type I interferon signalling and IFN&#x3b2;-1a. Biochim. Biophys. Acta Mol. Basis Dis. 2022;1868:166430. doi: 10.1016/j.bbadis.2022.166430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2022.166430</ArticleId><ArticleId IdType="pubmed">35550850</ArticleId></ArticleIdList></Reference><Reference><Citation>Magusali N., Graham A.C., Piers T.M., Panichnantakul P., Yaman U., Shoai M., Reynolds R.H., Botia J.A., Brookes K.J., Guetta-Baranes T., et al. A genetic link between risk for Alzheimer&#x2019;s disease and severe COVID-19 outcomes via the OAS1 gene. Brain. 2021;144:3727&#x2013;3741. doi: 10.1093/brain/awab337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab337</ArticleId><ArticleId IdType="pmc">PMC8500089</ArticleId><ArticleId IdType="pubmed">34619763</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalovicz L.T., Lally B., Konat G.W. Peripheral challenge with a viral mimic upregulates expression of the complement genes in the hippocampus. J. Neuroimmunol. 2015;285:137&#x2013;142. doi: 10.1016/j.jneuroim.2015.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2015.06.003</ArticleId><ArticleId IdType="pmc">PMC4673984</ArticleId><ArticleId IdType="pubmed">26198930</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrisko T.J., Bloemer J., Pinky P.D., Srinivas S., Heslin R.T., Du Y., Setti S.E., Hong H., Suppiramaniam V., Konat G.W., et al. Neuronal CXCL10/CXCR3 Axis Mediates the Induction of Cerebral Hyperexcitability by Peripheral Viral Challenge. Front. Neurosci. 2020;14:220. doi: 10.3389/fnins.2020.00220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00220</ArticleId><ArticleId IdType="pmc">PMC7105801</ArticleId><ArticleId IdType="pubmed">32265633</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabrucker S., Marizzoni M., Silajd&#x17e;i&#x107; E., Lopizzo N., Mombelli E., Nicolas S., Dohm-Hansen S., Scassellati C., Moretti D.V., Rosa M., et al. Microbiota from Alzheimer&#x2019;s patients induce deficits in cognition and hippocampal neurogenesis. Brain. 2023;146:4916&#x2013;4934. doi: 10.1093/brain/awad303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad303</ArticleId><ArticleId IdType="pmc">PMC10689930</ArticleId><ArticleId IdType="pubmed">37849234</ArticleId></ArticleIdList></Reference><Reference><Citation>Viengkhou B., Hofer M.J. Breaking down the cellular responses to type I interferon neurotoxicity in the brain. Front. Immunol. 2023;14:1110593. doi: 10.3389/fimmu.2023.1110593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1110593</ArticleId><ArticleId IdType="pmc">PMC9936317</ArticleId><ArticleId IdType="pubmed">36817430</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M., Shiwaku H., Tanaka H., Obita T., Ohuchi S., Yoshioka Y., Jin X., Kondo K., Fujita K., Homma H., et al. Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation. Nat. Commun. 2021;12:6565. doi: 10.1038/s41467-021-26851-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26851-2</ArticleId><ArticleId IdType="pmc">PMC8592984</ArticleId><ArticleId IdType="pubmed">34782623</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy E.R., Chiu G., Li S., Propson N.E., Kanchi R., Wang B., Coarfa C., Zheng H., Cao W. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid &#x3b2; plaques. Immunity. 2022;55:879&#x2013;894.e6. doi: 10.1016/j.immuni.2022.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.03.018</ArticleId><ArticleId IdType="pmc">PMC9109419</ArticleId><ArticleId IdType="pubmed">35443157</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Liu P. Cytosolic DNA sensing by cGAS: Regulation, function, and human diseases. Signal Transduct. Target. Ther. 2021;6:170. doi: 10.1038/s41392-021-00554-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00554-y</ArticleId><ArticleId IdType="pmc">PMC8085147</ArticleId><ArticleId IdType="pubmed">33927185</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi U.Y., Kang J.-S., Hwang Y.S., Kim Y.-J. Oligoadenylate synthase-like (OASL) proteins: Dual functions and associations with diseases. Exp. Mol. Med. 2015;47:e144. doi: 10.1038/emm.2014.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.110</ArticleId><ArticleId IdType="pmc">PMC4351405</ArticleId><ArticleId IdType="pubmed">25744296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang M., Zhao Y., Yu H., Li S., Liu T., Chen L., Chen J., Luo Y., Guo X., Wei X., et al. XAF1 promotes anti-RNA virus immune responses by regulating chromatin accessibility. Sci. Adv. 2023;9:eadg5211. doi: 10.1126/sciadv.adg5211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adg5211</ArticleId><ArticleId IdType="pmc">PMC10438455</ArticleId><ArticleId IdType="pubmed">37595039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanford S.A.I., Miller L.V.C., Vaysburd M., Keeling S., Tuck B.J., Clark J., Neumann M., Syanda V., James L.C., McEwan W.A. The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology. Alzheimer&#x2019;s Dement. 2024;10:1013&#x2013;1025. doi: 10.1002/alz.13493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.13493</ArticleId><ArticleId IdType="pmc">PMC10916982</ArticleId><ArticleId IdType="pubmed">37849026</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Primio C., Quaranta P., Mignanelli M., Siano G., Bimbati M., Scarlatti A., Piazza C.R., Spezia P.G., Perrera P., Basolo F., et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus. 2023;2:pgad282. doi: 10.1093/pnasnexus/pgad282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgad282</ArticleId><ArticleId IdType="pmc">PMC10508204</ArticleId><ArticleId IdType="pubmed">37731949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., Muller L., Ostermann P.N., Gabriel E., Abida-Islam P., Muller-Schiffmann A., Mariappan A., Goureau O., Gruell H., Walker A., et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 2020;39:e106230. doi: 10.15252/embj.2020106230.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xe4;ufer C., Schreiber C.S., Hartke A.S., Denden I., Stanelle-Bertram S., Beck S., Kouassi N.M., Beythien G., Becker K., Schreiner T., et al. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine. 2022;79:103999. doi: 10.1016/j.ebiom.2022.103999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103999</ArticleId><ArticleId IdType="pmc">PMC9013202</ArticleId><ArticleId IdType="pubmed">35439679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Li C., Yoon C., Leung O.W., You S., Cui X., Chan J.F., Pei D., Cheung H.H., Chu H. Enhanced replication of SARS-CoV-2 Omicron BA.2 in human forebrain and midbrain organoids. Signal Transduct. Target Ther. 2022;7:381. doi: 10.1038/s41392-022-01241-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01241-2</ArticleId><ArticleId IdType="pmc">PMC9676899</ArticleId><ArticleId IdType="pubmed">36411276</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine K.S., Leonard H.L., Blauwendraat C., Iwaki H., Johnson N., Bandres-Ciga S., Ferrucci L., Faghri F., Singleton A.B., Nalls M.A. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023;111:1086&#x2013;1093.e2. doi: 10.1016/j.neuron.2022.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.12.029</ArticleId><ArticleId IdType="pmc">PMC10079561</ArticleId><ArticleId IdType="pubmed">36669485</ArticleId></ArticleIdList></Reference><Reference><Citation>Green R., Mayilsamy K., McGill A.R., Martinez T.E., Chandran B., Blair L.J., Bickford P.C., Mohapatra S.S., Mohapatra S. SARS-CoV-2 infection increases the gene expression profile for Alzheimer&#x2019;s disease risk. Mol. Ther.-Methods Clin. Dev. 2022;27:217&#x2013;229. doi: 10.1016/j.omtm.2022.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2022.09.007</ArticleId><ArticleId IdType="pmc">PMC9508696</ArticleId><ArticleId IdType="pubmed">36187720</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizio J.D., Gulen M.F., Saidoune F., Thacker V.V., Yatim A., Sharma K., Nass T., Guenova E., Schaller M., Conrad C., et al. The cGAS&#x2013;STING pathway drives type I IFN immunopathology in COVID-19. Nature. 2022;603:145&#x2013;151. doi: 10.1038/s41586-022-04421-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04421-w</ArticleId><ArticleId IdType="pmc">PMC8891013</ArticleId><ArticleId IdType="pubmed">35045565</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Tang W., Ibrahim F., Chen X., Yan H., Tao C., Wang Z., Guo Y., Fu Y., Wang Q., et al. A&#x3b2; Induces Neuroinflammation and Microglial M1 Polarization via cGAS-STING-IFITM3 Signaling Pathway in BV-2 Cells. Neurochem. Res. 2023;48:2881&#x2013;2894. doi: 10.1007/s11064-023-03945-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-023-03945-5</ArticleId><ArticleId IdType="pubmed">37210413</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaidt M.M., Ebert T.S., Chauhan D., Ramshorn K., Pinci F., Zuber S., O&#x2019;Duill F., Schmid-Burgk J.L., Hoss F., Buhmann R., et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3. Cell. 2017;171:1110&#x2013;1124.e18. doi: 10.1016/j.cell.2017.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.039</ArticleId><ArticleId IdType="pmc">PMC5901709</ArticleId><ArticleId IdType="pubmed">29033128</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Hu D., Wu C., Feng Y., Li A., Liu W., Wang Y., Chen K., Tian M., Xiao F., et al. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog. 2020;16:e1008335. doi: 10.1371/journal.ppat.1008335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008335</ArticleId><ArticleId IdType="pmc">PMC7080238</ArticleId><ArticleId IdType="pubmed">32187211</ArticleId></ArticleIdList></Reference><Reference><Citation>Stancu I.-C., Cremers N., Vanrusselt H., Couturier J., Vanoosthuyse A., Kessels S., Lodder C., Br&#xf4;ne B., Huaux F., Octave J.-N., et al. Aggregated Tau activates NLRP3&#x2013;ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol. 2019;137:599&#x2013;617. doi: 10.1007/s00401-018-01957-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-01957-y</ArticleId><ArticleId IdType="pmc">PMC6426830</ArticleId><ArticleId IdType="pubmed">30721409</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S., Sittenfeld L., Dridi H., Liu Y., Liu X., Marks A.R. Alzheimer&#x2019;s-like signaling in brains of COVID-19 patients. Alzheimers&#x2019;s Dement. 2022;18:955&#x2013;965. doi: 10.1002/alz.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., et al. SARS-CoV-2 crosses the blood&#x2013;brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct. Target. Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Haferkamp U., Pfefferle S., Woo M.S., Heinrich F., Schweizer M., Appelt-Menzel A., Cubukova A., Barenberg J., Leu J., et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17:307&#x2013;320. doi: 10.1016/j.stemcr.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang K., Wu L., Luo Y., Gong B. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019. J. Med. Virol. 2021;93:3165&#x2013;3175. doi: 10.1002/jmv.26876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26876</ArticleId><ArticleId IdType="pmc">PMC8014647</ArticleId><ArticleId IdType="pubmed">33590923</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott A.M., Jager A.C., Gwin M., Voth S., Balczon R., Stevens T., Lin M.T. Pneumonia-induced endothelial amyloids reduce dendritic spine density in brain neurons. Sci. Rep. 2020;10:9327. doi: 10.1038/s41598-020-66321-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-66321-1</ArticleId><ArticleId IdType="pmc">PMC7283224</ArticleId><ArticleId IdType="pubmed">32518286</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.T., Balczon R., Pittet J.F., Wagener B.M., Moser S.A., Morrow K.A., Voth S., Francis C.M., Leavesley S., Bell J., et al. Nosocomial Pneumonia Elicits an Endothelial Proteinopathy: Evidence for a Source of Neurotoxic Amyloids in Critically Ill Patients. Am. J. Respir. Crit. Care Med. 2018;198:1575&#x2013;1578. doi: 10.1164/rccm.201801-0060LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201801-0060LE</ArticleId><ArticleId IdType="pmc">PMC6298632</ArticleId><ArticleId IdType="pubmed">30280916</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.R., Kandel R., Tripathi S., Condon D., Qi L., Taubenberger J., Hartshorn K.L. Alzheimer&#x2019;s associated &#x3b2;-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS ONE. 2014;9:e101364. doi: 10.1371/journal.pone.0101364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0101364</ArticleId><ArticleId IdType="pmc">PMC4079246</ArticleId><ArticleId IdType="pubmed">24988208</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastore A., Raimondi F., Rajendran L., Temussi P.A. Why does the A&#x3b2; peptide of Alzheimer share structural similarity with antimicrobial peptides? Commun. Biol. 2020;3:135. doi: 10.1038/s42003-020-0865-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-0865-9</ArticleId><ArticleId IdType="pmc">PMC7081199</ArticleId><ArticleId IdType="pubmed">32193491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafran N., Shafran I., Ben-Zvi H., Sofer S., Sheena L., Krause I., Shlomai A., Goldberg E., Sklan E.H. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci. Rep. 2021;11:12703. doi: 10.1038/s41598-021-92220-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92220-0</ArticleId><ArticleId IdType="pmc">PMC8209102</ArticleId><ArticleId IdType="pubmed">34135459</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoades N.S., Pinski A.N., Monsibais A.N., Jankeel A., Doratt B.M., Cinco I.R., Ibraim I., Messaoudi I. Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose. Cell Rep. 2021;36:109637. doi: 10.1016/j.celrep.2021.109637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109637</ArticleId><ArticleId IdType="pmc">PMC8361213</ArticleId><ArticleId IdType="pubmed">34433082</ArticleId></ArticleIdList></Reference><Reference><Citation>Voth S., Gwin M., Francis C.M., Balczon R., Frank D.W., Pittet J.-F., Wagener B.M., Moser S.A., Alexeyev M., Housley N., et al. Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions. FASEB J. 2020;34:9156&#x2013;9179. doi: 10.1096/fj.202000051RRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000051RRR</ArticleId><ArticleId IdType="pmc">PMC7383673</ArticleId><ArticleId IdType="pubmed">32413239</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>